UT Austin's Simulation and Game Applications (SAGA) Lab develops software for funded projects and assists in preparing grant proposals. We create games, interactive/immersive environments, mobile apps, web dashboards, game-simulations, and VR/AR software solutions. The SAGA Lab and partnering UT faculty co-design the software solution, which is developed by paid student-interns. We have a long track record of creating software solutions for research and education spanning nearly 10 years.

The Texas Global Health Security Innovation Consortium (TEXGHS) connects academic, public- and private-sector partners to support companies working towards pandemic preparedness and response in Texas. TEXGHS is developing a health security innovation ecosystem that supports innovators and innovations fighting COVID-19 and future pandemics. UT Austin entrepreneurs should contact TEXGHS when they are seeking to commercialize infectious disease-related innovations at any stage of development.

The Texas Innovation Center offers a personalized environment for faculty and students to explore entrepreneurship that includes educational workshops, speaker series, coaching sessions, and direct guidance for technology commercialization pathways; from ideation to market validation to fundraising. We accomplish this through Startup-In-A-Box Resources, TxIC Friends and Mentors Network, Innovation Lab, and co-working space. A place to inspire, create and commercialize.

The Texas Institute for Discovery Education in Science (TIDES) aims to catalyze, support, and showcase innovative, evidence-based undergraduate science education in the College of Natural Sciences. TIDES serves a variety of connected roles: creating and connecting students to experiential learning opportunities; facilitating curriculum reform efforts and faculty development across the sciences; and collecting, curating, and analyzing data to steer TIDES and college evaluation efforts.

Drug development services including preclinical evaluation (animal and analytical), development, and translation of drug products and technologies that improve healthcare outcomes. Access to equipment and services, such as small animal studies (mice, rats, hamsters), cell culture, material characterization (NGI, Spraytec, Zetasizer), formulation development, dissolution and stability studies, as well as quantitative small molecule HPLC and mass spec analyses.